ACT1, a synthetic peptide designed to mimic the C-terminus of the gap junction protein connexin 43 (Cx43), with high binding specificity to the tight junction associated protein zona occludens (ZO-1).
ACT1 peptide is a synthetic connexin43 mimetic peptide that has garnered significant attention in the field of carbohydrate compound research due to its unique ability to modulate gap junction communication. As a specialized peptide, ACT1 is designed to interact with the carboxyl-terminal domain of connexin43, a protein crucial for intercellular signaling and tissue homeostasis. Its robust structure and high specificity make it an invaluable tool for investigating cell signaling pathways, wound healing mechanisms, and tissue regeneration models. The versatility of ACT1 peptide extends to a range of experimental settings, where it serves both as a research probe and as a modulator of cellular communication, advancing our understanding of complex biological processes.
Cell Signaling Studies: ACT1 peptide is extensively used to dissect the intricate mechanisms of cell-to-cell communication, particularly in the context of gap junctions formed by connexin43. By mimicking the functional domains of connexin43, it enables researchers to selectively modulate gap junction intercellular communication (GJIC) without affecting other connexin isoforms. This selective modulation is instrumental in elucidating the role of connexin43 in various physiological and pathological processes, such as cardiac conduction, neural signaling, and tissue response to injury. The peptide's application in cell culture systems allows for precise investigation of how altered GJIC influences cellular behavior, thus providing deeper insights into the regulatory networks governing tissue function.
Wound Healing Research: In the realm of tissue repair and regeneration, ACT1 has emerged as a preferred tool for studying the dynamics of wound closure and cellular migration. By influencing connexin43-mediated signaling, it facilitates the coordination of cellular responses that are essential for effective tissue remodeling. Experimental models utilizing ACT1 demonstrate enhanced migration of keratinocytes and fibroblasts, which are crucial for re-epithelialization and extracellular matrix formation. This makes the peptide a valuable asset for exploring novel therapeutic strategies aimed at accelerating wound healing and minimizing scarring, thereby contributing to the development of advanced biomaterial and tissue engineering solutions.
Inflammation Modulation: The role of ACT1 in modulating inflammatory responses is another area of active research. By targeting connexin43, the peptide helps regulate the passage of ions and small signaling molecules between adjacent cells, which in turn affects the propagation of inflammatory signals. Studies have shown that modulation of connexin43 activity can influence the recruitment and activation of immune cells at sites of tissue injury or infection. As a result, ACT1 is frequently employed in in vitro and ex vivo models to investigate the molecular pathways underlying inflammation, offering a strategic approach to unraveling the complexities of immune cell communication.
Neuroscience Applications: In neuroscience, ACT1 peptide provides a sophisticated means to probe the function of gap junctions in neuronal and glial networks. Connexin43 is abundantly expressed in astrocytes, where it plays a pivotal role in maintaining homeostatic balance and supporting neuronal health. By modulating gap junction coupling, ACT1 enables researchers to study the impact of altered intercellular communication on synaptic activity, neuroprotection, and glial cell function. These studies are critical for advancing our understanding of the cellular mechanisms involved in neurodegenerative diseases, brain injury, and neuroinflammation.
Cardiac Research: The peptide's application extends into cardiac research, where connexin43 is a key determinant of electrical coupling and impulse propagation in the heart. ACT1 serves as a powerful tool for investigating the molecular basis of arrhythmogenesis and cardiac remodeling by allowing selective modulation of gap junctions in cardiac tissues. Through its use in cell and tissue models, researchers can explore how changes in connexin43-mediated communication affect cardiac rhythm, contractility, and response to injury, paving the way for novel interventions targeting cardiac dysfunction.
Tissue Engineering and Regenerative Medicine: The integration of ACT1 peptide into tissue engineering frameworks exemplifies its potential to enhance the design and functionality of biomaterials. By modulating intercellular communication, the peptide can be incorporated into scaffolds or hydrogels to promote coordinated cellular activity, which is essential for successful tissue regeneration. This approach supports the development of advanced materials that mimic the dynamic signaling environments of native tissues, facilitating improved integration and functional recovery in engineered constructs. Overall, ACT1 peptide stands out as a multifaceted research tool, driving innovation across diverse fields such as cell biology, wound repair, inflammation, neuroscience, cardiac research, and tissue engineering.
3. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More